Results 211 to 220 of about 85,355 (254)

Can Mammography and Magnetic Resonance Imaging Predict the Preoperative Size and Nuclear Grade of Pure Ductal Carcinoma In Situ? [PDF]

Diagnostics (Basel)
Çetin Tunçez H, Bulut MG, Adıbelli ZH, Bozer A, Kart BA, Kocatepe Çavdar D.   +5 more
europepmc   +1 more source

Mutational landscape of pure ductal carcinoma in situ and associations with disease prognosis and response to radiotherapy. [PDF]

Breast Cancer Res
Rizvi N, Mucaki EJ, Salmini EL, Zhang M, Trebinjac S, Hahn E, Paszat L, Nofech-Mozes S, Hallett MT, Rakovitch E, Dumeaux V.   +10 more
europepmc   +1 more source

Correction: Analysis of ductal carcinoma in situ by self-reported race reveals molecular differences related to outcome. [PDF]

Breast Cancer Res
Strand SH, Houlahan KE, Branch V, King LM, Lynch T, Rivero-Guitiérrez B, Harmon B, Couch F, Gallagher K, Kilgore M, Wei S, DeMichele A, King T, McAuliffe P, Curtis C, Owzar K, Marks JR, Colditz GA, Hwang ES, West RB.   +19 more
europepmc   +1 more source

Cancer outcomes in women without upfront surgery for ductal carcinoma in situ: observational cohort study. [PDF]

BMJ
Ryser MD, Thomas SM, Li Y, Lynch T, Barber A, Francescatti AB, Collyar D, Byng D, Grimm LJ, Partridge AH, Thompson AM, Hyslop T, Hwang ES.   +12 more
europepmc   +1 more source

Influence of Cancerization of Lobules in Ductal Carcinoma In Situ of the Breast on the Pathological Outcomes in Mastectomy Specimens. [PDF]

Cancers (Basel)
Alloush F, Bahmad HF, Deb A, Ocejo S, Valencia AK, Abulaban A, Krishnamurthy K, Alghamdi S, Poppiti R.   +8 more
europepmc   +1 more source

Decoding tumor-infiltrating lymphocytes heterogeneity in ductal carcinoma in situ: immune microenvironment dynamics and prognostic insights. [PDF]

Discov Oncol
Wang L, Yang Y, Song Y, Zeng J, Zheng H, Wu X.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Ductal Carcinoma In Situ

Surgical Clinics of North America, 2018
Ductal carcinoma in situ has been stable in incidence for a decade and has an excellent prognosis. Breast conservation therapy is safe and effective for most patients. Adjuvant whole breast radiation therapy is recommended to reduce the risk of local recurrence.
FangMeng, Fu, Richard C, Gilmore, Lisa K, Jacobs   +2 more
  +7 more sources

Ductal carcinoma in situ

Surgical Clinics of North America, 2003
DCIS is a heterogeneous disease whose natural history is poorly defined. Screening mammography has increased the detection rate of DCIS, but we remain unable to identify cases of DCIS that will not progress to invasive carcinoma during an individual's lifetime.
Faina, Nakhlis, Monica, Morrow
openaire   +2 more sources

Ductal Carcinoma In Situ

Human Pathology, 1996
In the past 10 years clinical trials have confirmed the value of breast conserving therapy for invasive breast cancer and many authorities now consider this the preferred and appropriate treatment (NCI Consensus Statement 1992a). However controversy still surrounds the treatment of ductal carcinoma in situ (DCIS).
openaire   +3 more sources